As GLP-1 supplements continue to be a prominent topic among health-conscious Americans, the discussion has now extended to pets. Better Choice has partnered with Aimia Pet Health to explore a GLP-1 supplement for overweight pets under its Halo brand. This new launch targets the nearly half of the world's overweight or obese dogs and cats, who suffer from similar weight-related health complications as humans, such as diabetes, arthritis, and high blood pressure.
According to the brand, "the goal of our research and development is to replicate the weight loss benefits of leading human brands, such as Slentrol, Wegovy, Ozempic, and Monjaro, while adding protein and nutrients from our Halo products to promote lean muscle and overall pet health." Notably, the new products include treats and toppers to safely combat pet obesity.
Animal-Focused GLP-1 Supplements
Better Choice Announces Partnership with Aimia Pet Health
Trend Themes
1. Pet Obesity Solutions - Innovative GLP-1 supplements specifically formulated for pets provide a new avenue for tackling the growing issue of pet obesity.
2. Human-pet Health Parallels - Advancements in pet healthcare are increasingly mirroring human healthcare trends, leveraging similar treatments for common conditions like obesity and diabetes.
3. Functional Pet Foods - The integration of dietary supplements into pet treats and foods represents a growing trend in enhancing pet health through everyday nutrition.
Industry Implications
1. Pet Healthcare - The emergence of GLP-1 supplements for pets highlights expansion opportunities within the specialized pet healthcare sector.
2. Nutraceuticals - Nutraceuticals are seeing a crossover into the pet market, showing potential for growth and innovation in health-boosting pet products.
3. Veterinary Services - Veterinary services are evolving to include advanced treatments and dietary recommendations, reflecting a broader acceptance of integrated pet health management.